PhDcandidate

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.

蔻享学术，一站式科学服务平台，致力于在直播录像、精品课程、会议服务、青少年科普、新媒体开发运维等学术领域，为客户提供一站式、全流程、立体化科学服务。

利群读书会

DeepScienceisaninnovativeintelligentdigitalplatformforinternationalresearcher.Combiningpreprinthostingandopenpeerreviewwithintelligence,DeepScienceaimstobetheleadingpublishingvenueforscholarlyresearchworldwide.

toeflwritingforanacademicdiscussion

AcademicIdeas是一款热门的AI论文工具软件，具备选题、文献检索、写作助手等多项实用功能，极大地提高了研究者的论文写作效率和质量。

TheENREACHbrandwaslaunchedin2014toprovideasetofgiftedandtalentedenrichmentprogramstoenhanceChinesestudents’academiclife.

万方学术搜索系统(WANFANGAcademicSearchSystem)由北京万方软件有限公司(Infosoft)推出，面向公共图书馆、高校图书馆，提供海量学术文献资源的统一检索、资源揭示、知识分析、原文调度及数字图书馆服务。

科检易学术（ScienceandTechnologyInspectionYiAcademic）致力于为广大专家学者提供学术期刊发表、期刊匹配、论文翻译、润色编辑等多方位出版支持的服务，为学术成果的传播、科学技术的发展服务，助推中国学术高质量发展。

TheSingaporeInternationalEducationAssociation(SIEA)isaregisteredassociationinSingapore.TheassociationisdeeplycommittedtofosteringacademiccollaborationandfacilitatingmeaningfulexchangesbetweenSingapore’seducationsectorandtheglobalacademiccommunity.

广泛联系了包括1000多名两院院士、200多位国务院部委专家、3000多位全国各省市学术带头人、国家重点实验室负责人，与中国科学院、清华大学、北京大学、浙江大学等国内顶尖高校、知名科研院所、企事业单位专家深入交流，切实推动地方的可持续发展，实现院士科研成果与产业升级的有力结合。

北京艾迪润色专业为您提供sci论文润色|sci英文润色|sci文章润色|论文翻译润色|中文论文翻译|sci论文翻译|EssayProofreading|PaperProofreading|AcademicLanguageProofreading|sci英文论文润色|Proofreading|文章润色|论文润色的相关信息,想要了解更多详情,请联系我们.

深圳市学术科技有限公司是领先的学术团体、科研院所信息化网络系统提供商，专业承接会员系统、会议系统、评奖系统和高校教务管理系统软件开发。

Discover,explore,andstayupdatedwiththelatestresearchpapersusingLLM-poweredsemanticsearchandpersonalizedrecommendations.DailyupdatesfromarXivandmore.

Yourone-stopAIsolutionforacademicwritingneeds.ProDream'sAIwritingassistantboostsyourspeed,sharpensskills,assistswithresearchpapers,streamlinescitations,andpreventsplagiarism.

www.stzacademics.com

NYUShanghai